Andre Boonstra
Overview
Explore the profile of Andre Boonstra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
160
Citations
3609
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Farag M, van Campenhout M, Sonneveld M, Fung S, van Erpecum K, Wong D, et al.
J Viral Hepat
. 2024 Jan;
31(4):197-207.
PMID: 38243144
We studied whether 48 weeks of PEG-IFN alfa-2a add-on increases HBsAg-decline and clearance in HBeAg-negative patients on long-term nucleo(s)tide analogue (NA) therapy. In this investigator-initiated, randomized, controlled trial conducted in...
12.
Devillers M, Pluimers J, van Hooff M, Doukas M, Polak W, de Man R, et al.
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201435
Introduction: AFP and the RETREAT score are currently used to predict HCC recurrence after LT. However, superior discriminating models are needed for low AFP populations. The aim of this study...
13.
Brakenhoff S, Claassen M, Honkoop P, de Knegt R, van der Eijk A, Boonstra A, et al.
Clin Res Hepatol Gastroenterol
. 2023 Dec;
48(2):102257.
PMID: 38065523
Background & Aim(s): Current guidelines suggest that nucleos(t)ide analogues (NA) can be discontinued before HBsAg loss in a selected group of chronic hepatitis B (CHB) patients. We aimed to study...
14.
Fu S, Karim D, Prieto J, Balderramo D, Ferrer J, Mattos A, et al.
Ann Hepatol
. 2023 Nov;
29(2):101181.
PMID: 37981236
Introduction And Objectives: Tolloid like protein 1 (TLL1) rs17047200 has been reported to be associated with HCC development and liver fibrosis. However, to our knowledge, no studies have been performed...
15.
Fu S, Deger T, Boers R, Boers J, Doukas M, Gribnau J, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835478
Aberrant DNA methylation changes have been reported to be associated with carcinogenesis in cirrhotic HCC, but DNA methylation patterns for these non-cirrhotic HCC cases were not examined. Therefore, we sought...
16.
Sonneveld M, Chiu S, Park J, Brakenhoff S, Kaewdech A, Seto W, et al.
Gastroenterology
. 2023 Sep;
166(1):168-177.e8.
PMID: 37769952
Background & Aims: Patients who discontinue nucleo(s)tide analogue therapy are at risk of viral rebound and severe hepatitis flares, necessitating intensive off-treatment follow-up. Methods: We studied the association between hepatitis...
17.
Ayoub A, Anugwom C, Prieto J, Balderramo D, Ferrer J, Mattos A, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760499
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide. The rs7574865 genetic variant has been associated with an increased risk of developing HCC in Asian populations. However,...
18.
Beudeker B, Fu S, Balderramo D, Mattos A, Carrera E, Diaz J, et al.
Hepatol Commun
. 2023 Sep;
7(10).
PMID: 37708457
Background: HCC is a major cause of cancer death worldwide. Serum biomarkers such as alpha-fetoprotein (AFP), protein induced by vitamin K absence-II, and the Gender, Age, AFP-L3, AFP, Des-gamma-carboxy prothrombin...
19.
Goble S, Akambase J, Prieto J, Balderramo D, Ferrer J, Mattos A, et al.
Dig Dis Sci
. 2023 Sep;
68(11):4212-4220.
PMID: 37684433
Background: The rs641738 C > T single-nucleotide polymorphism of MBOAT7 has been associated with hepatocellular carcinoma (HCC) and nonalcoholic fatty liver disease (NAFLD). Latin Americans have high rates of HCC...
20.
Sonneveld M, Chiu S, Park J, Brakenhoff S, Kaewdech A, Seto W, et al.
JHEP Rep
. 2023 Jul;
5(8):100790.
PMID: 37484211
Background & Aims: Pretreatment predictors of finite nucleo(s)tide analogue (NUC) therapy remain elusive. We studied the association between pretreatment HBV DNA levels and outcomes after therapy cessation. Methods: Patients with...